tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
ALNY is currently covered by 23 analysts with an average price target of $445.73. This is a potential upside of $69.52 (88.69%) from yesterday's end of day stock price of $236.22.
Alnylam Pharmaceuticals's activity chart (see below) currently has 650 price targets and 541 ratings on display. The stock rating distribution of ALNY is 81.97% BUY and 18.03% HOLD.
Analysts average stock forecasts to be materialized ratio is 84.23% with an average time for these price targets to be met of 216.83 days.
Highest price target for ALNY is $566, Lowest price target is $256, average price target is $445.73.
Most recent stock forecast was given by DAVID LEBOWITZ from BMO on 19-Aug-2026.
Currently out of the existing stock ratings of ALNY, 50 are a BUY (81.97%), 11 are a HOLD (18.03%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Mar-2025
$318
$81.78 (34.62%)
$380
Hold Since 20-Oct-2025
$256
$19.78 (8.37%)
$316
Buy Since 21-Jul-2025
$315
$78.78 (33.35%)
$410
Buy Since 29-Jul-2025
$420
$183.78 (77.80%)
$472
Buy Since 28-Jun-2024
$450
$213.78 (90.50%)
$527
What is ALNY (Alnylam Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ALNY (Alnylam Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ALNY (Alnylam Pharmaceuticals)?
Which analyst is the currently most bullish on ALNY (Alnylam Pharmaceuticals)?
Which analyst is the currently most reserved on ALNY (Alnylam Pharmaceuticals)?
